Journey Medical Corporation
DERM
$6.07
-$0.11-1.78%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.90% | -5.63% | |||
| Total Other Revenue | 207.69% | -97.85% | |||
| Total Revenue | -0.73% | -8.80% | |||
| Cost of Revenue | 14.30% | -5.47% | |||
| Gross Profit | -8.42% | -10.42% | |||
| SG&A Expenses | 2.49% | -18.18% | |||
| Depreciation & Amortization | 5.73% | 0.09% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.63% | -13.77% | |||
| Operating Income | -236.79% | 71.03% | |||
| Income Before Tax | -78.83% | 46.13% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -78.83% | 46.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -78.83% | 46.13% | |||
| EBIT | -236.79% | 71.03% | |||
| EBITDA | -158.84% | 233.76% | |||
| EPS Basic | -77.61% | 50.43% | |||
| Normalized Basic EPS | -77.08% | 50.34% | |||
| EPS Diluted | -77.61% | 50.43% | |||
| Normalized Diluted EPS | -77.08% | 50.34% | |||
| Average Basic Shares Outstanding | 0.74% | 8.60% | |||
| Average Diluted Shares Outstanding | 0.74% | 8.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||